TG Therapeutics, Inc. (TGTX) stock analysis

TGTX · TG Therapeutics, Inc.

Latest recorded price: USD 62.76

Sector and industry: Healthcare · Biotechnology

A reliable intrinsic value could not be calculated for TGTX; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 504.9%, free cash flow margin -4.1%, ROIC 11.6%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare